Client Result

MRD Monitoring Market Assessment and Strategy

Project Overview

A diagnostics player wanted to determine which indications and use cases to target and develop a product road map for its planned MRD offering

DeciBio Approach

Primary Research

  • Interviewed 30 U.S.-based oncologists covering 10+ indications to identify and prioritize use cases and indications for future business development
  • Interviews spanned a representative mix of generalists and specialists, and clinicians from both the community and academic settings

Secondary Research

  • Identified and characterized MRD trials
  • Reviewed MRD development pipelines of key market players
  • Benchmarked MRD assay specifications against each other and stakeholder perspectives of performance requirements
At a glance
60
Potential Use Cases Assessed
12
Indications Investigated
30
Interviews
Outcomes

DeciBio presented to the client a deliverable discussing discrete use cases of the highest interest to the client team, and deep dives of each.  The report included an assessment of:

  • U.S. ctDNA MRD and monitoring market opportunity
  • Top use cases prioritized by clinical need, competitive opportunity, and alignment with client technology and capabilities
  • Customer feeback on pain points, unmet needs, and opportunities for differentiation in the MRD space

The client leveraged this output to prioritize investments into 3 specific indication-application areas for the development of its planned MRD assay.

Timeline

7 weeks

Geographic Scope

U.S.

Industry

Clinical Diagnostics

capabilities

Biomarker and Diagnostic Strategy

Go-to-Market Strategy

Competitive Analysis

Voice-Of-Customer Research

Related Client Results
Clinical Diagnostics
Genetic Testing Lab Target Assessment
A large pharmaceutical company asked DeciBio to help it identify and evaluate clinical genetic testing labs for potential partnership or acquisition
Target Identification
Clinical Diagnostics
Early Cancer Detection Competitor Landscape Monitoring
A top diagnostics player wanted to monitor the commercial, clinical, research, and corporate activities in the public domain for three of the key players in the cancer early detection market.
Competitive Analysis
Clinical Diagnostics
IVDR Diagnostics Strategy
A top-10 diagnostics company wanted to gauge laboratory preparedness and reactions to the impending implementation of IVDR, and how that would impact portfolio strategy
Voice-Of-Customer Research
Biomarker and Diagnostic Strategy
Clinical Diagnostics
Oncology Diagnostics Landscape Assessment and Model
DeciBio performed a global voice-of-customer (VOC) research campaign with oncologists and pathologists to understand the current adoption and expected trends for NGS kits in oncology diagnostics in the U.S., EU, and APAC.
Voice-Of-Customer Research
Biomarker and Diagnostic Strategy

Precision Medicine is evolving at a rapid pace

Discover how we can help

Contact Us
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Precision Medicine. Precision Insights.
© DeciBio 2022. All rights reserved.
Privacy | Terms & Conditions